Evidence map›Paper›PMID 34000278›Full record

ArticleKidney international2021

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.

Vivette D D'Agati, Satoru Kudose, Andrew S Bomback, Ananea Adamidis, Albert Tartini

Abstract readCase ReportsLetter
In one paragraph

Article in Kidney international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Vaccines and nephrotic syndrome: efficacy and safety.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2023
    Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Vivette D D'AgatiDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: vdd1@cumc.columbia.edu.
Satoru KudoseDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.
Andrew S BombackDepartment of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.
Ananea AdamidisDepartment of Medicine, Division of Nephrology, Holy Name Medical Center, Teaneck, New Jersey, USA.
Albert TartiniDepartment of Medicine, Division of Nephrology, Holy Name Medical Center, Teaneck, New Jersey, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryCOVID-19Nephrosis, LipoidAgedBNT162 VaccineCOVID-19 VaccinesHumansMaleBNT162 VaccineCOVID-19 Vaccines

Identifiers

PMID34000278
PMCPMC8123374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.